No Data
No Data
Ho\'s Ophthalmology: 2024 Semi-Annual Report Summary
Ho\'s Ophthalmology: Semi-Annual Report 2024
Huan Shi Ophthalmology (301103.SZ) released its performance for the first half of the year, with a net income of 24.064 million yuan, a decrease of 69.29% year-on-year.
He Shi Eye Hospital (301103.SZ) released its 2024 interim report, reporting a revenue of 5... for the reporting period...
CEO Wei He, Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) Largest Shareholder Sees Value of Holdings Go Down 12% After Recent Drop
Ho's Ophthalmology (301103.SZ) plans to distribute 10 shares of 6.050416 yuan to be deducted from interest on July 5
Heshi Ophthalmology (301103.SZ) announcement, the company's annual equity distribution in 2023 will be distributed to all shareholders at a rate of 10 shares per...
Heshi Ophthalmology (301103.SZ): Cumulative expenditure of 67.5 million yuan to repurchase 1.72% of the shares.
On June 20th, Gelonhui reported that as of June 19th, 2024, the company has repurchased a total of 2,722,719 shares through a share repurchase special securities account using centralized bidding trading, accounting for 1.72% of the company's total share capital. The highest fill price was 31.36 yuan/share, the lowest fill price was 19.98 yuan/share, and the total trade amount was 67,503,537.37 yuan (excluding transaction fees). As of the disclosure date of this announcement, the company's share repurchase plan has been completed.
No Data